Get the Stockscreener App
2.02
3.81%
-0.08
After Hours:
2.02
Annovis Bio Inc stock is traded at $2.02, with a volume of 273.11K.
It is down -3.81% in the last 24 hours and down -9.01% over the past month.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
See More
Previous Close:
$2.10
Open:
$2.08
24h Volume:
273.11K
Relative Volume:
0.47
Market Cap:
$39.36M
Revenue:
-
Net Income/Loss:
$-30.26M
P/E Ratio:
-0.9902
EPS:
-2.04
Net Cash Flow:
$-24.69M
1W Performance:
-6.05%
1M Performance:
-9.01%
6M Performance:
+25.47%
1Y Performance:
-77.78%
1-Day Range:
$1.954
$2.0894
1-Week Range:
$1.954
$2.2926
52-Week Range:
$1.11
$9.23
Annovis Bio Inc Stock (ANVS) Company Profile
Name
Annovis Bio Inc
Sector
Industry
Phone
484-875-3192
Address
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA
Compare ANVS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANVS
Annovis Bio Inc
|
2.02 | 48.93M | 0 | -30.26M | -24.69M | -2.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Annovis Bio Inc Stock (ANVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-25 | Downgrade | D. Boral Capital | Buy → Hold |
| Oct-25-24 | Upgrade | Maxim Group | Hold → Buy |
| Dec-29-23 | Initiated | Canaccord Genuity | Buy |
| Jul-07-21 | Reiterated | Maxim Group | Buy |
Annovis Bio Inc Stock (ANVS) Latest News
How geopolitical risks impact Annovis Bio Inc. stockJuly 2025 Breakouts & Verified Entry Point Signals - newser.com
Can momentum traders help lift Annovis Bio Inc.July 2025 Volume & Fast Gain Swing Trade Alerts - newser.com
Is a relief rally coming for Annovis Bio Inc. holdersJuly 2025 Decliners & Fast Gaining Stock Strategy Reports - newser.com
Why Annovis Bio Inc. stock could be next big winner2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com
How Annovis Bio Inc. stock compares with top peers2025 Risk Factors & Accurate Intraday Trade Tips - newser.com
What does recent volatility data suggest for Annovis Bio Inc.Quarterly Earnings Summary & Low Risk Entry Point Guides - newser.com
Will Annovis Bio Inc. stock see insider accumulationJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com
Is Annovis Bio Inc. stock dividend yield sustainableRate Cut & Low Risk Investment Opportunities - newser.com
Can Annovis Bio Inc. stock hit record highs againJuly 2025 Reactions & Low Risk Entry Point Guides - newser.com
Annovis Bio Inc. stock volume spike explainedJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com
Is Annovis Bio Inc. stock undervalued vs historical averagesWeekly Profit Analysis & Low Risk Entry Point Guides - newser.com
Custom watchlist performance reports with Annovis Bio Inc.Market Performance Summary & Community Consensus Picks - newser.com
Why retail traders accumulate Annovis Bio Inc. stock2025 Trade Ideas & High Win Rate Trade Tips - newser.com
Is Annovis Bio Inc. stock attractive for passive investors2025 Macro Impact & Weekly Momentum Stock Picks - newser.com
How Annovis Bio Inc. stock trades during market volatilityDividend Hike & Safe Capital Growth Plans - newser.com
Can volume confirm reversal in Annovis Bio Inc.2025 Institutional Moves & Community Verified Swing Trade Signals - newser.com
What data driven models say about Annovis Bio Inc.’s futureQuarterly Growth Report & Daily Oversold Stock Bounce Ideas - newser.com
Can Annovis Bio Inc. rally from current levelsQuarterly Trade Report & Proven Capital Preservation Methods - newser.com
How to track smart money flows in Annovis Bio Inc.Analyst Upgrade & Low Drawdown Investment Strategies - newser.com
Is Annovis Bio Inc. trending in predictive chart models2025 Market Outlook & Smart Swing Trading Alerts - newser.com
Why Annovis Bio Inc. stock stays on buy listsMarket Movement Recap & Low Risk Investment Opportunities - newser.com
Using data models to predict Annovis Bio Inc. stock movement2025 Performance Recap & Technical Pattern Based Signals - newser.com
Can Annovis Bio Inc. stock continue upward trend2025 Retail Activity & Fast Exit Strategy with Risk Control - newser.com
Tools to assess Annovis Bio Inc.’s risk profileRate Hike & AI Driven Stock Reports - newser.com
Will Annovis Bio Inc. stock benefit from automation2025 Analyst Calls & Growth Oriented Trading Recommendations - newser.com
Annovis Bio Inc Stock (ANVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):